Avacta Group plc, the developer of Affimer ® biotherapeutics and reagents, is pleased to announce that it will launch an ELISA laboratory test for the SARS-CoV-2 spike protein to support global ...
IRVINE, Calif., June 16, 2020 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ: BMRA) announced today they have submitted to the FDA an EUA application for an ELISA lab-based serology blood test for the ...
SAN DIEGO, Dec. 03, 2020 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or the “Company”), an international healthcare solutions company targeting oncological ...
CAMBRIDGE & WETHERBY, England--(BUSINESS WIRE)--Avacta Group plc (AIM: AVCT), the developer of Affimer® biotherapeutics and reagents, is pleased to announce that it will launch an ELISA laboratory ...
Enzyme-linked immunosorbent assays (ELISAs) represent the gold standard for quantitatively detecting protein biomarkers, and are used for applications such as diagnosing or monitoring disease, ...
Lucknow: A state-level training of lab technicians and non-medical scientists on Elisa-based testing for lab diagnosis of dengue and chikungunya was held at SGPGIMS. Anchored by the Viral Research and ...
New Delhi, May 22 (IANS) In a first of its kind technology, a test would now help rapid and accurate estimation of total antibody concentration of Covid-19 in clinical samples. The novelty of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results